Drug prescription in diabetic patients in Stockholm in 1992 and 1995 - Change over time

被引:23
作者
Wandell, PE
Brorsson, B
Aberg, H
机构
[1] KAROLINSKA INST, DEPT CLIN NEUROSCI & FAMILY MED, DIV FAMILY MED, STOCKHOLM, SWEDEN
[2] SWEDISH COUNCIL TECHNOL ASSESSMENT HLTH CARE, STOCKHOLM, SWEDEN
基金
巴西圣保罗研究基金会;
关键词
diabetes mellitus; Sweden; drug utilisation; antidiabetic drugs; cardiovascular agents; lipid-lowering drugs; primary health care;
D O I
10.1007/s002280050285
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective: To describe and compare the distribution of prescribed drugs in diabetic patients between 1992 and 1995. Methods: Two cross-sectional surveys of a random selection of medical records of diabetic patients, from three community health centres (CHCs) in the Stockholm metropolitan area, were carried out. The age of the subjects ranged from 20 to 84 years. The number of prescriptions of pharmaceutical preparations given to the diabetic patients was noted, as well as classification of the diabetes, the metabolic outcome, and concomitant hypertension. Results: Between 1992 and 1995, the use of oral antidiabetics increased significantly from 43 to 57% of the patients and the rate of treatment with diet only decreased from 30 to 20%. Combination treatment with oral drugs and insulin rose significantly from 1 to 8% of the patients. However, the greatest increase observed between 1992 and 1995 concerns cardiovascular drugs. The prescription rate of ACE inhibitors increased from 5 to 21%, of loop diuretics from 19 to 28%, of ASA from 9 to 21%, and of lipid-lowering agents from 1 to 7%. There was also a considerable variation between the three CHCs. Despite the more aggressive diabetic treatment strategies, the metabolic state was unchanged and unsatisfactory for 40-50% of the patients. Conclusions: There have been major changes towards more active pharmacological treatment regarding antidiabetic, cardiovascular, and lipid-lowering agents.
引用
收藏
页码:249 / 254
页数:6
相关论文
共 34 条
[1]   MANAGEMENT OF NON-INSULIN-DEPENDENT DIABETES-MELLITUS IN EUROPE - A CONSENSUS VIEW [J].
ALBERTI, KGMM ;
GRIES, FA .
DIABETIC MEDICINE, 1988, 5 (03) :275-281
[2]  
[Anonymous], 1995, Br. Med. J, DOI DOI 10.1136/BMJ.310.6972.83
[3]   TREATMENT OF ARTERIAL-HYPERTENSION IN DIABETIC HUMANS - IMPORTANCE OF THERAPEUTIC SELECTION [J].
BAKRIS, GL ;
BARNHILL, BW ;
SADLER, R .
KIDNEY INTERNATIONAL, 1992, 41 (04) :912-919
[4]  
CAVELLA MJ, 1994, ARCH INTERN MED, V154, P625
[5]   RATIONAL PRESCRIBING AND INTERPRACTITIONER VARIATION - A MULTILEVEL APPROACH [J].
DAVIS, P ;
GRIBBEN, B .
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 1995, 11 (03) :428-442
[6]   PREVALENCE OF DEPRESSION IN ADULTS WITH DIABETES - AN EPIDEMIOLOGIC EVALUATION [J].
GAVARD, JA ;
LUSTMAN, PJ ;
CLOUSE, RE .
DIABETES CARE, 1993, 16 (08) :1167-1178
[7]   USE OF HEALTH MAINTENANCE ORGANIZATION DATA-BASES TO STUDY PHARMACY RESOURCE USAGE IN DIABETES-MELLITUS [J].
GLAUBER, HS ;
BROWN, JB .
DIABETES CARE, 1992, 15 (07) :870-876
[8]   DRUG CONSUMPTION IN ELDERLY DIABETICS [J].
GRAM, J ;
DAMSGAARD, EM .
DIABETES RESEARCH AND CLINICAL PRACTICE, 1989, 7 (04) :293-298
[9]   The effects of high- and medium-dose metformin therapy on cardiovascular risk factors in patients with type II diabetes [J].
Grant, PJ .
DIABETES CARE, 1996, 19 (01) :64-66
[10]   VARIATIONS IN RESOURCE UTILIZATION AMONG MEDICAL SPECIALTIES AND SYSTEMS OF CARE - RESULTS FROM THE MEDICAL OUTCOMES STUDY [J].
GREENFIELD, S ;
NELSON, EC ;
ZUBKOFF, M ;
MANNING, W ;
ROGERS, W ;
KRAVITZ, RL ;
KELLER, A ;
TARLOV, AR ;
WARE, JE .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 267 (12) :1624-1630